Cargando…
Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience
COVID-19 is causing a high influx of patients suffering from serious respiratory complications leading the necessity to find effective therapies. These patients seem to present with cytokine perturbation and high levels of IL6. Tocilizumab and sarilumab could be effective in this condition. We retro...
Autores principales: | Castelnovo, Laura, Tamburello, Antonio, Lurati, Alfredo, Zaccara, Eleonora, Marrazza, Maria Grazia, Olivetti, Micol, Mumoli, Nicola, Mastroiacovo, Daniela, Colombo, Daniele, Ricchiuti, Elisabetta, Vigano’, Paolo, Paola, Faggioli, Mazzone, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793456/ https://www.ncbi.nlm.nih.gov/pubmed/33429732 http://dx.doi.org/10.1097/MD.0000000000023582 |
Ejemplares similares
-
Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
por: Laria, Antonella, et al.
Publicado: (2022) -
Monocytes could be a bridge from inflammation to thrombosis on COVID-19 injury: A case report
por: Mazzone, Antonino, et al.
Publicado: (2020) -
Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling
por: Zizzo, Gaetano, et al.
Publicado: (2022) -
Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati, Alfredomaria, et al.
Publicado: (2021) -
Clinical Features, Short-Term Mortality, and Prognostic Risk Factors of Septic Patients Admitted to Internal Medicine Units: Results of an Italian Multicenter Prospective Study
por: Mazzone, Antonino, et al.
Publicado: (2016)